Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)
Treatment of Ph+ Relapsed/Refractory ALL
Treatment of Ph- Relapsed/Refractory ALL
Reducing the Risk of Severe Illness for Patients With COVID-19
A ACCME Accredited provider.
The France Foundation ©
Chandler Building, 84 Lyme Street, Old Lyme, CT USA